{"id":"W4311765023","doi":"10.1016/j.eururo.2022.11.025","title":"Corrigendum to “Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study” [Eur Urol 83 (2023) 15–26]","year":2022,"lang":"en","type":"erratum","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Olaparib; Pembrolizumab; Prostate cancer; Oncology; Internal medicine; Cohort; Urology; Gynecology; Cancer; Immunotherapy; Poly ADP ribose polymerase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00109288,0.0009462752,0.001483726,0.0005111687,0.0004629145,0.0001372002,0.0008833667,0.00014466,0.0007822323],"category_scores_gemma":[0.0003460536,0.0006352878,0.0001718377,0.0009500079,0.0002796071,0.0001063356,0.0005638805,0.002667691,0.0002313533],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001055043,"about_ca_system_score_gemma":0.002136562,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003368162,"about_ca_topic_score_gemma":0.00715571,"domain_scores_codex":[0.991577,0.002277632,0.001326957,0.001972375,0.001563009,0.001283019],"domain_scores_gemma":[0.9964941,0.0002513448,0.0006696669,0.001698758,0.0004025726,0.0004836014],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.1527857,0.007471684,0.2478196,0.0002020375,0.003635026,0.02117129,0.008957072,0.0002346158,0.00003434498,0.000003561958,0.55286,0.004825067],"study_design_scores_gemma":[0.0724615,0.01615075,0.8034719,0.0001740683,0.001618959,0.00002688978,0.0002674933,0.00007119741,0.000003629358,0.000003049694,0.105098,0.0006525378],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9446099,0.004098353,0.000009443359,0.003058196,0.01257813,0.01593336,0.009460949,0.0002244972,0.01002711],"genre_scores_gemma":[0.8526568,0.0006921308,0.00002730953,0.001901476,0.001053031,0.001509949,0.01686067,0.0005139291,0.1247847],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5556523,"threshold_uncertainty_score":0.9996332,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03189533556481511,"score_gpt":0.3104238590029311,"score_spread":0.278528523438116,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}